Accordingly, natural cytotoxicity receptor NKp46 and granzyme B have been reported to be expressed by atypical cells in some CD4+ CTCL cases, including MF and pcALCL patients69–71. The gene discussed is CD4; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.